GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate

Methotrexate (MTX) is an antifolate drug used as a chemotherapeutic agent for acute lymphoblastic leukemia, where MTX improves patients' prognosis. Macrophage reprogramming is being increasingly assessed as an antitumor therapeutic strategy. However, and although MTX limits the pathogenic actio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ríos, Israel, López-Navarro, Baltasar, Torres-Torresano, Mónica, Soler Palacios, Blanca, Simón-Fuentes, Miriam, Domínguez-Soto, Ángeles, Muller, Ittai B., Jansen, Gerrit, Corbí, Ángel L., Puig-Kröger, Amaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643894/
https://www.ncbi.nlm.nih.gov/pubmed/36380627
http://dx.doi.org/10.1159/000526622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643894/
https://www.ncbi.nlm.nih.gov/pubmed/36380627
http://dx.doi.org/10.1159/000526622

Ejemplares similares